STAAR Surgical Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from STAAR Surgical Company's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-0.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 63% of Healthcare companies in United States.
Cash Locked Ratio
$40For every $100 of sales, $40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $26 tied up three years earlier.
More money tied up than 82% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 0/3Sales grew in 1 of the last 3 years; profit grew in 0 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 16%
Sales fell 16% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-16% / +8%In 3 years sales changed by -16% while total assets changed by +8%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-5.8×Operating cash was negative last year, while some debt falls due within a year.
Higher than 58% of Healthcare companies in United States.
Cash Cushion Ratio
+13%Cash, after subtracting all debt, equals 13% of its market value (net cash).
Higher than 55% of Healthcare companies in United States.
Tangible Assets Ratio
93%Of every $100 the company owns, $93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 66% of Healthcare companies in United States.
Tangible Net Worth Ratio
91%Of every $100 of net worth, $91 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 73% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
STAAR Surgical Company owes $0.23 for every $1 it owns. STAAR Surgical Company made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
281.1Investors pay $281.1 for every $1 of STAAR Surgical Company's yearly profit, higher than 97% of Healthcare companies in United States.
P/B ratio
3.09The share price is 3.09 times STAAR Surgical Company's book value per share, higher than 57% of Healthcare companies in United States.
Market cap
$1.1 BThe total market value of all of STAAR Surgical Company's shares at today's price (share price × number of shares), larger than 65% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$365 MWhat STAAR Surgical Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$7.29Net worth divided by the number of shares. The share price of $22.49 is 3.1 times this, which is the P/B above.
Return on equity (ROE)
1.1%STAAR Surgical Company earned 1.1% on its shareholders' money over the last year, higher than 76% of Healthcare companies in United States.
Owes vs Owns
0.23×STAAR Surgical Company owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.
Dividend yield
NoneSTAAR Surgical Company does not currently pay a dividend.
Revenue growth
-24%Revenue fell 24% in the year to Dec 2025, and shrank 6% a year on average over 3 years.
Profit growth
LossSTAAR Surgical Company made a loss in each of the last two years.
Profit margin
-33.6%STAAR Surgical Company lost $34 for every $100 of revenue.
Cash vs debt
Net cashSTAAR Surgical Company held $149 M more cash than debt (net cash) at Dec 2025.
Questions
What is STAAR Surgical Company's P/E ratio?
Investors pay $281.1 for every $1 of STAAR Surgical Company's yearly profit, higher than 97% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For STAAR Surgical Company: $1.1 B ÷ $365 M (30 Jun 2026) = 3.1.
What is STAAR Surgical Company's return on equity?
STAAR Surgical Company earned 1.1% on its shareholders' money over the last year, higher than 76% of Healthcare companies in United States.
How much does STAAR Surgical Company owe compared with what it owns?
STAAR Surgical Company owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.
Does STAAR Surgical Company pay a dividend?
No. STAAR Surgical Company does not currently pay a dividend.
Is STAAR Surgical Company's revenue growing?
Revenue fell 24% in the year to Dec 2025, and shrank 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.